Clinical Trial Update: A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ferumoxytol for treatment of iron deficiency anemia in pediatric subjects. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: RECRUITING